K. Altundag Et Al. , "Which is better in neoadjuvant treatment of breast cancer? Taxane followed by anthracyline or vice versa," BREAST CANCER RESEARCH AND TREATMENT , vol.97, no.2, pp.221, 2006
Altundag, K. Et Al. 2006. Which is better in neoadjuvant treatment of breast cancer? Taxane followed by anthracyline or vice versa. BREAST CANCER RESEARCH AND TREATMENT , vol.97, no.2 , 221.
Altundag, K., Altundag, O., Baptista, M., & Atik, M., (2006). Which is better in neoadjuvant treatment of breast cancer? Taxane followed by anthracyline or vice versa. BREAST CANCER RESEARCH AND TREATMENT , vol.97, no.2, 221.
Altundag, K Et Al. "Which is better in neoadjuvant treatment of breast cancer? Taxane followed by anthracyline or vice versa," BREAST CANCER RESEARCH AND TREATMENT , vol.97, no.2, 221, 2006
Altundag, K Et Al. "Which is better in neoadjuvant treatment of breast cancer? Taxane followed by anthracyline or vice versa." BREAST CANCER RESEARCH AND TREATMENT , vol.97, no.2, pp.221, 2006
Altundag, K. Et Al. (2006) . "Which is better in neoadjuvant treatment of breast cancer? Taxane followed by anthracyline or vice versa." BREAST CANCER RESEARCH AND TREATMENT , vol.97, no.2, p.221.
@article{article, author={K Altundag Et Al. }, title={Which is better in neoadjuvant treatment of breast cancer? Taxane followed by anthracyline or vice versa}, journal={BREAST CANCER RESEARCH AND TREATMENT}, year=2006, pages={221} }